|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Double- blind, Placebo- controlled, Multicenter, Randomized, Phase iib neoadjuvant study of letrozole-lapatinib in post- menopausal hormone receptor-positive, Human epidermal growth factor receptor2-negative, Operable breast cancer 显示文摘 | Guameri V Generali DG Frassoldati A | 2014 | Clin 0ncol2014，32，10： | 1 |
| 2 | Clean-up of aqueous acetone vegetable extracts by solid-matrix partition for pyrethroid residue determination by gas - chromatography - electron - capture detection显示文摘 | MUCCIO A D BARBINI D A GENERALI T | 1997 | J Chromatogr A1997，765，： | 1 |
| 3 | Clean-up of aqueous acetone vegetable extracts by soild-matrix partition for pyrethroid residue determination by gas chromagraphy-electron-capture detection显示文摘 | Muccio A D Barbini D A Generali T | 1997 | J Chromatography A1997，765，： | 1 |
| 4 | Single-step separation of organochlorine pesticide residues from fatty materials by combined use of solid-matrix partition and C18 cartridges显示文摘 | MUCCIO A D GENERALI T BARBINI D A | 1997 | J Chromatogr A1997，765，： | 1 |
| 5 | International ex- pert consensus on primary systemic therapy in the manage- ment of early breast cancer: highlights of the Fourth Sympo- sium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010) 显示文摘 | Berruti A Generali D Kaufmann M | 2011 | J Natl Cancer Inst Monogr2011，，43： | 1 |
| 6 | Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expres- sion in endothelial cell function显示文摘 | Patel N S Li J L Generali D Poulsom R Cranston D W Harris A L | 2005 | Cancer Res2005，65，： | 1 |
| 7 | Interventional therapy in diabetic foot: risk, factors, clinical events and prognosis at one year follow-up (a study of 103 case$)显示文摘 | Ciccone MM Marchese A Generali A | 2012 | Pak J Biol Sci2012，15，16： | 1 |
| 8 | Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients 显示文摘 | Bottini A Generali D Brizzi MP | 2006 | J Clin Oncol2006，24，22： | 1 |
| 9 | Randomized phase Ⅱ trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients显示文摘 | Bottini A Generali D Brizzi MP | 2006 | J Clin Oncol2006，24，22： | 1 |
| 10 | Immunomodulation of FOXP3^+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients 显示文摘 | Generali D Bates G Berruti A | 2009 | Clin Cancer Res2009，15，3： | 1 |
| 11 | Immunomodulatlon of FOXP3 + regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients 显示文摘 | Generali D Bates G Berruti A | 2009 | Clin Cancer Res2009，15，3： | 1 |
| 12 | Clean-up of aqueous acetone vegetable extracts by solid-matrix partition for pyrethroid residue determination by gas chromatography--electron-capture detection显示文摘 | DI MUCCIO A BARBINI D A GENERALI T | 1997 | Journal of Chromatography A1997，765，1： | 1 |
| 13 | Interventional therapy in diabetic foot:risk factors,clinical events and prognosis at one year follow-up(a study of 103 cases)显示文摘 | Ciccone MM Marchese A Generali A | 2012 | Pak J Biol Sci2012，15，16： | 1 |
| 14 | Immunomodulation of Foxp3+ regulatory T cells by the aromatase inhibitor ~etrozole ~n breast cancer pat~ents显示文摘 | Generali D Bates G Berruti A | 2009 | CIin Cancer Res2009，15，3： | 1 |
| 15 | The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load显示文摘 | GENERALI D BERRUTI A TAMPELLINI M | 2007 | Bone2007，40，1： | 1 |
| 16 | Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years显示文摘 | Selmi C Ceribelli A Generali E et aI | 2016 | Autoimmun Rev2016，15，2： | 1 |
| 17 | International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010) 显示文摘 | Berruti A Generali D Kaufmann M | 2011 | J Natl Cancer Inst Monogr2011，2011，43： | 1 |
| 18 | Interventional therapy in diabetic foot: risk factors, clinical events and prognosis at one year follow-up (a study of 103 cases)显示文摘 | Ciccone MM Marchses A Generali A | 2012 | Pak J Biol Sci2012，15，16： | 1 |
| 19 | Metformin:Prevention and Treatment of Antipsychotic-Induced Weight Gain显示文摘 | GENERALI J A CADA J D | 2013 | Hosp Pharm2013，48，73： | 1 |
| 20 | Hypoxia-inducible factor- 1 alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer显示文摘 | Generali D Berruti A Brizzi MP | 2006 | Clin Cancer Res2006，12，15： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员